RA Capital Management - PMV PHARMACEUTICALS INC ownership

PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.

Quarter-by-quarter ownership
RA Capital Management ownership history of PMV PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$20,352,000
-16.5%
1,710,2650.0%0.43%
-33.2%
Q2 2022$24,371,000
-31.6%
1,710,2650.0%0.65%
-16.3%
Q1 2022$35,608,000
-9.9%
1,710,2650.0%0.78%
+11.5%
Q4 2021$39,507,000
-22.5%
1,710,2650.0%0.70%
-1.3%
Q3 2021$50,966,000
-12.8%
1,710,2650.0%0.71%
-24.7%
Q2 2021$58,423,000
+3.9%
1,710,2650.0%0.94%
+10.6%
Q1 2021$56,251,000
-46.5%
1,710,2650.0%0.85%
-42.4%
Q4 2020$105,198,000
+73.3%
1,710,2650.0%1.47%
+32.4%
Q3 2020$60,714,0001,710,2651.11%
Other shareholders
PMV PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,614,911$19,217,00059.24%
Euclidean Capital LLC 2,336,909$27,809,00025.82%
OUP Management Co., LLC 989,232$11,772,00018.33%
Nextech Invest Ltd. 1,385,807$16,491,0005.33%
Boxer Capital, LLC 3,163,795$37,649,0002.12%
PERSONAL CFO SOLUTIONS, LLC 550,342$6,549,0001.64%
Orbimed Advisors 6,563,077$78,101,0001.45%
RTW INVESTMENTS, LP 4,356,920$51,847,0001.20%
ACUTA CAPITAL PARTNERS, LLC 154,500$1,839,0000.79%
Monarch Partners Asset Management LLC 210,370$2,503,0000.75%
View complete list of PMV PHARMACEUTICALS INC shareholders